The use of temozolomide as a radiosensitiser for the treatment of newly diagnosed glioblastoma multiforme

Publisher： Cambridge University Press

E-ISSN： 1467-1131|6|2|103-110

ISSN： 1460-3969

Source： Journal of Radiotherapy in Practice, Vol.6, Iss.2, 2007-06, pp. : 103-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Infrared Thermography in Surgery of Newly Diagnosed Glioblastoma Multiforme: A Technical Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 350-355

Karger

Access to resources Recommend Favorite

Stereotactic radiosurgery for patients with newly diagnosed glioblastoma multiforme (GBM): comparison with intra-operative radiotherapy and evaluation of prognostic factors

By  

Journal of Radiotherapy in Practice, Vol. 6, Iss. 3, 2007-09 ,pp. : 143-152

Cambridge University Press

Access to resources Recommend Favorite

Temozolomide in Newly Diagnosed Malignant Gliomas: Administered Concomitantly with Radiotherapy, and Thereafter as Consolidation Treatment

By  

Oncology Research and Treatment, Vol. 31, Iss. 6, 2008-05 ,pp. : 309-313

Karger

Access to resources Recommend Favorite

Aspergillosis in a Patient Receiving Temozolomide for the Treatment of Glioblastoma

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-08 ,pp. : 410-415

Karger

Access to resources Recommend Favorite

Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme

By  

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 2926-2932

John Wiley & Sons Inc

Access to resources Recommend Favorite